S21 Cardio biochemistry Atherosclerosis Flashcards
formation fo ahterosclerotic plaque
modified LDLs readily penetrate arterial endothelia; increases adhesion expression
less LDL receptor mediated uptake and more scavenger (SR-B1) uptake promoting monocyte differentiation to macrophage and foam cells
monocytes and platelets recruited to sub-endothelial space: elicit inflammatory response.
LDL degraded to produce foam cell macrophage with accumulated cholesterol. foam cells secrete factors to activate SMC proliferation and ECM deposition.
dying macrophage leave behind other atherosclerotic plaque on innermost layer of artery
II-A (hypercholesterolemia)
common
familial hypercholesterolemia, combined hyperlipidemia
polygenic hypercholesterolemia
LDL elevated
CHOL elevated
severe atherogenicity
II-b (combined hyperlipemia)
most common
familial combined hyperlipidemia
unclassified
LDL, VLDL elevated
CHOL, TG elevated
Severe atherogenicity
IV (endogenous hyperlipemia)
common
Familial hypertriglyceridemia (mild)
Familial combined hyperlipidemia
Sporadic combined hypertriglyceridemia
Tangier’s Disease
VLDL elevated
TG elevated
mild to moderate atherogenicity
Monogenic hyperlipoproteinemias
gene defects causing hyperlipoproteinemias are often monogenic and fall into 4 categories
- Aloliprotein disorders: Apo A, B, CII, E
- Enzyme disorders: lipoprotein lipase, hepatic lipase, lecithin: cholesterol Acyl transferase
- Receptor Disorder: LDL Receptor, Cholesterol Ester Transfer Protein, Microsomal Transfer Protein, ABC1 transfer protein
- other: chylomicron retention disease
LDL receptor mutations (5 types_
apoB100 deficiencies often present with
xanthomas of eyes, skin and feet
Metabolic syndrome is defined by
hypertriglyceridemia >150
low HDL cholesterol <5o in women, <40 in men
hypertension >130/85 mmHg
increased waist circumference >35 in women, >40 in men
elevated fasting blood glucose >100 mg/dl
insulin in lipid metabolism
suppresses adipocyte lipolysis by hormone sensitive lipase
surpasses hepatic VLDL production
stimulates uptake of FFA from TRL into adipocytes and non-hepatic peripheral tissues by LPL